Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 |
Autore | Ecke Thorsten |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (240 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
Metallothionein
urothelium urothelial cancer cadmium exposure zinc transporter bladder TAGLN F-actin PTEN p53 tumorigenesis proliferation invasion TERT promoter mutations FGFR3 non muscle invasive bladder cancer BCG therapy bladder cancer JAK-STAT pathway combination therapy oncolytic adenovirus virotherapy STAT3/5 inhibitor JAK inhibitor XVir-N-31 bladder cancer detection urinary biomarkers DNA methylation ECRG4 ITIH5 biomarker cancer grade metabolomics MS NMR biomarkers tumor markers prognosis heparanase syndecan-1 heparan sulfate proteoglycans (HSPGs) urothelial carcinoma miRNA quantitative PCR tumor marker voided urine cytology KDM7A histone demethylase TC-E 5002 androgen receptor drug resistance non-invasive detection telomerase somatic mutations TERT promoter region muscle-invasive bladder cancer chemotherapy immunotherapy personalized medicine predictive biomarker survivin BIRC5 macrophage KRT20 ERBB2 MIBC prediction RT-qPCR adjuvant chemotherapy survival |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557142003321 |
Ecke Thorsten
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Integrating Clinical and Translational Research Networks-Building Team Medicine |
Autore | Salgia Ravi |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (250 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
renal cell carcinoma
team medicine translational research community practice clinical trials geriatric oncology older adults cancer clinical trials recruitment community team science bladder cancer urothelial carcinoma COVID-19 team-based medicine colorectal cancer precisian medicine academic and community oncology cancer center lung cancer lung cancer screening low-dose CT scans cancer prevention smoking cessation tobacco control national guidelines for screening and prevention pharmaceutical aids to smoking cessation non-small cell lung cancer driver mutations testing rates receptor tyrosine kinases actionable mutations next-generation sequencing fast-and-frugal trees personalized medicine minorities ethnicity race breast cancer research HER2-directed therapy community oncology academic cancer center precision medicine cancer genetics cancer genomics small cell lung cancer immunotherapy epithelial ovarian cancer frontline treatment surgical debulking adjuvant chemotherapy maintenance therapy PARP inhibitor genetics counseling clinical research oropharyngeal cancer concurrent chemoradiation therapy human papillomavirus feeding tube dependency value-based care value-based cancer care oncology pathways Early Recovery After Surgery (ERAS) team-based care oncology medical home integrated cancer care supportive care pathways surgical pathways cancer care plans |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557124403321 |
Salgia Ravi
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments |
Autore | Uchino Junji |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (258 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
non-small cell lung cancer
previously treated patients phase I/II trial chemotherapy docetaxel S-1 immunotherapy rechallenge retrospective analysis pulmonary pleomorphic carcinoma prognostic factor glucose transporter 1 lung cancer multiple cancers metastasis sequencing mutation genomic diagnosis FDG-PET immune checkpoint inhibitor PD-1 prognosis RAD51B methylation PD-L1 expression predictive biomarker PD-1 blockade interstitial lung disease pulmonary fibrosis radiology and other imaging non-small-cell lung cancer epidermal growth factor receptor tyrosine kinase inhibitors TP53 mutations responsiveness targeted therapy network meta-analysis stage IIIA-N2 surgery immune checkpoint inhibitors biomarker nonsmall cell lung cancer HIP1R PD-L1 RUNX1 methylation survival EGFR-TKI T790M osimertinib immune-related adverse events endocrine disorders tumor-bearing patients PD-1 inhibitors PD-L1 inhibitors meta-analysis nivolumab Expanded Access Program real-world data daily practice prognostic factors NSCLC KRAS DNA polymerase beta platinum-based first-line adjuvant chemotherapy β-catenin lung neoplasms nucleotide-diphosphate kinase recurrence unresectable salvage surgery oligometastasis |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Non-small Cell Lung Cancer |
Record Nr. | UNINA-9910557489703321 |
Uchino Junji
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Precision Medicine in Solid Tumors |
Autore | Dey Nandini |
Pubbl/distr/stampa | Basel, : MDPI Books, 2022 |
Descrizione fisica | 1 electronic resource (304 p.) |
Soggetto topico |
Medicine
Oncology |
Soggetto non controllato |
pediatric tumors
tumor mutational burden TMB whole-exome sequencing gene panel sequencing immune checkpoint inhibitors glioblastoma prognosis overall survival extent of resection random forest Decision tree personalized precision oncology circulating free DNA liquid biopsy epidermal growth factor receptor tyrosine kinase inhibitor osimertinib comprehensive genomic profiling molecular genotyping intratumor heterogeneity multiple biopsies tumor evolution clonality classification strategic therapeutic intervention thymoma driver mutation sequencing molecular barcoding EGFR mutation EGFR-TKI cfDNA NGS digital enrichment next-generation sequencing solid cancer universal health-care system precision medicine presumed germline findings clinical guideline non-small cell lung cancer outcome adjuvant chemotherapy anaplastic lymphoma receptor tyrosine kinase HNSCC ctDNA tDNA DDR genes PARP inhibitors new drug development next-generation sequencing (NGS) open data regulatory reform tumor profiling test triple-negative breast cancer (TNBC) breast cancer targeted therapy TNBC subtypes immunotherapy cancer screening smoking electronic records PD-L1 cancer-associated fibroblasts resistance chemotherapy CTC immunocytochemistry parallel double-detection laboratory-friendly |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910595078103321 |
Dey Nandini
![]() |
||
Basel, : MDPI Books, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Surgical Treatment of Pancreatic Ductal Adenocarcinoma |
Autore | Satoi Sohei |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (214 p.) |
Soggetto topico |
Medicine
Surgery |
Soggetto non controllato |
unresectable pancreatic ductal adenocarcinoma
conversion surgery early recurrence pancreatic neoplasm/analysis pancreatic neoplasm/surgery tumor location survival clinical staging branch duct intraductal papillary mucinous neoplasm risk factor malignancy meta-analysis laparoscopic pancreaticoduodenectomy pancreatic cancer borderline resectable neoadjuvant treatment chemoradiotherapy prognostic nutritional index isolated local recurrence pancreatectomy pancreatic remnant recurrence redo surgery pancreatic exocrine insufficiency adjuvant chemotherapy biliary drainage prehabilitation ERAS arterial resection total pancreatectomy neoadjuvant therapy pancreatic ductal adenocarcinoma surgical treatment technical advances pancreatic main duct dilatation intraductal papillary mucinous neoplasm high grade dysplasia invasive carcinoma pancreatic cystic neoplasm cell-free DNA mesopancreas superior mesenteric artery nerve and fibrous tissues lymph node dissection R0 resection |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557364803321 |
Satoi Sohei
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|